Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched the novel fixed-dose combination (FDC) drug – Indacaterol + Mometasone for patients suffering from […]
Tag: Glenmark
Glenmark concludes Hypertension Awareness Month
Glenmark Pharmaceuticals Limited (Glenmark) marked May as the Hypertension Awareness Month. Glenmark partnered with more 18,000 healthcare professionals (HCPs) from more than 8000 hospitals and […]
Glenmark launches “Hello Skin” – India’s first Whatsapp based chatbot to help patients suffering from fungal infections
An innovation-led global pharmaceutical company Glenmark Pharmaceuticals Ltd has developed an digital patient education tool – “Hello Skin” in collaboration with the IADVL (Indian Association […]
Glenmark launches First FDC Drug in India
An innovation-driven global pharmaceutical company Glenmark Pharmaceuticals Limited has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), […]
Glenmark launched Nitric Oxide Nasal Spray (FabiSpray®) in India
A worldwide, advancement driven drug organization Glenmark Pharmaceuticals Limited and Canadian drug organization SaNOtize Research and Development Corporation declared send off of its Nitric Oxide […]
Glenmark launch Remogliflozin + Vildagliptin + Metforminfixed dose combination
Glenmark Pharmaceuticals Limited (Glenmark), has launched a fixed dose combination (FDC) of its novel, patent protected, globally researched Sodium Glucose Co-Transporter Inhibitor(SGLT2i) – Remogliflozin Etabonate […]
GLENMARK SETS UP DEDICATED FABIFLU WEBPAGE & HELPLINE
Glenmark Pharmaceuticals has recently announced that they have begun work to increase Favipiravir tablet (brand name FabiFlu) production in the country. The drug firm stated […]
Glenmark launches Ryaltris-AZ
Glenmark Pharmaceuticals Limited announced the launch of Ryaltris-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark has been the […]
Glenmark’s Ryaltris nasal spray
Glenmark Pharmaceuticals Limited is concluding the final phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries […]
Glenmark and Menarini’s agreement for Ryaltris Nasal Spray
Glenmark Pharmaceuticals Limited’s (Glenmark) Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal […]